164 related articles for article (PubMed ID: 29892839)
1. Correlation of IGF1R expression with ABCG2 and CD44 expressions in human osteosarcoma.
Kim CK; Oh S; Kim SJ; Leem SH; Heo J; Chung SH
Genes Genomics; 2018 Apr; 40(4):381-388. PubMed ID: 29892839
[TBL] [Abstract][Full Text] [Related]
2. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 variants in osteosarcoma.
Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
[TBL] [Abstract][Full Text] [Related]
4. [Pilot study on the correlation between high incidence of CD44+/CD24 -/low/ABCG2- cells and poor prognosis in breast cancer].
Gong JF; Yuan YH; Song GH; Yu J; Han Y; Jia J; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):465-70. PubMed ID: 18931706
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of expression of cancer stem cell-related markers in orbital adenoid cystic carcinoma].
Lin TT; Zhu LM; He YJ; Zhang H
Zhonghua Yan Ke Za Zhi; 2011 Aug; 47(8):703-8. PubMed ID: 22169609
[TBL] [Abstract][Full Text] [Related]
6. [Expression of breast cancer resistance protein and p-glycoprotein in residual breast cancer tissue after chemotherapy and its correlation with cancer stem cells].
Qu HB; Fan YM; Han ML; Luo HJ; Xie J; Liu H; Liu H; Wu CY; Tang WX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):171-6. PubMed ID: 23643006
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract][Full Text] [Related]
9. Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells.
Xiao Z; Wan J; Nur AA; Dou P; Mankin H; Liu T; Ouyang Z
Cell Physiol Biochem; 2018; 51(4):1879-1893. PubMed ID: 30504723
[TBL] [Abstract][Full Text] [Related]
10. Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas.
Zambo I; Hermanova M; Zapletalova D; Skoda J; Mudry P; Kyr M; Zitterbart K; Sterba J; Veselska R
Cancer Biomark; 2016 Jun; 17(1):107-16. PubMed ID: 27314299
[TBL] [Abstract][Full Text] [Related]
11. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
Gerardo-RamÃrez M; Keggenhoff FL; Giam V; Becker D; Groth M; Hartmann N; Straub BK; Morrison H; Galle PR; Marquardt JU; Herrlich P; Hartmann M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955749
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of CD44 expression in osteosarcoma: evidence from six studies.
Liu Y; Wu Y; Gu S; Sun Z; Rui Y; Wang J; Lu Y; Li H; Xu K; Sheng P
Diagn Pathol; 2014 Aug; 9():140. PubMed ID: 25112408
[TBL] [Abstract][Full Text] [Related]
14. ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma.
Wang H; Luo F; Zhu Z; Xu Z; Huang X; Ma R; He H; Zhu Y; Shao K; Zhao J
BMC Cancer; 2017 Mar; 17(1):222. PubMed ID: 28347288
[TBL] [Abstract][Full Text] [Related]
15. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
16. Expression of the cancer stem cell markers CD44v6 and ABCG2 in tongue cancer: effect of neoadjuvant chemotherapy on local recurrence.
Yanamoto S; Yamada S; Takahashi H; Naruse T; Matsushita Y; Ikeda H; Shiraishi T; Seki S; Fujita S; Ikeda T; Asahina I; Umeda M
Int J Oncol; 2014 Apr; 44(4):1153-62. PubMed ID: 24504189
[TBL] [Abstract][Full Text] [Related]
17. Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence.
Lin PC; Lin HH; Lin JK; Lin CC; Yang SH; Li AF; Chen WS; Chang SC
Int J Biol Markers; 2013 Jun; 28(2):182-6. PubMed ID: 23558935
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.
Shi P; Liu W; Zhou ZT; He QB; Jiang WW
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437
[TBL] [Abstract][Full Text] [Related]
19. CCN2 promotes drug resistance in osteosarcoma by enhancing ABCG2 expression.
Tsai HC; Chang AC; Tsai CH; Huang YL; Gan L; Chen CK; Liu SC; Huang TY; Fong YC; Tang CH
J Cell Physiol; 2019 Jun; 234(6):9297-9307. PubMed ID: 30317661
[TBL] [Abstract][Full Text] [Related]
20. Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells.
Yang M; Yan M; Zhang R; Li J; Luo Z
Cancer Sci; 2011 Oct; 102(10):1774-81. PubMed ID: 21740477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]